Long COVID research plagued by flawed methods, say experts

Overly broad definitions, a lack of appropriate, or any, comparison groups, among other things, in studies looking at the incidence, prevalence, and control of the condition-;epidemiology-;have distorted the risks, say the researchers.

EC grants marketing authorisation for Sandoz’s Afqlir

Afqlir is set to combat blindness associated with neovascular age-related macular degeneration. Credit: SG SHOT/Shutterstock. The European Commission (EC) has granted marketing authorisation for Sandoz‘s

November 18, 2024

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production.

February 27, 2024

How Special Olympics kickstarted the push for better disability data

On July 1st, 1995, the world’s spotlight shone upon Yale’s football stadium in New Haven, Connecticut. It was the latest Special Olympics World Games, and

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.